Aligos Therapeutics Statistics
Total Valuation
ALGS has a market cap or net worth of $51.63 million. The enterprise value is -$50.84 million.
| Market Cap | 51.63M |
| Enterprise Value | -50.84M |
Important Dates
The last earnings date was Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALGS has 75.02 million shares outstanding. The number of shares has increased by 263.91% in one year.
| Shares Outstanding | 75.02M |
| Shares Change (YoY) | +263.91% |
| Shares Change (QoQ) | +143.00% |
| Owned by Insiders (%) | 20.39% |
| Owned by Institutions (%) | 60.53% |
| Float | 37.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.74 |
| Forward PS | n/a |
| PB Ratio | 0.86 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.25, with a Debt / Equity ratio of 0.18.
| Current Ratio | 6.25 |
| Quick Ratio | n/a |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.87 |
Financial Efficiency
Return on equity (ROE) is -144.20% and return on invested capital (ROIC) is -122.73%.
| Return on Equity (ROE) | -144.20% |
| Return on Assets (ROA) | -84.50% |
| Return on Capital (ROIC) | -122.73% |
| Revenue Per Employee | $208,970 |
| Profits Per Employee | -$1.51M |
| Employee Count | 66 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALGS has paid $780,000 in taxes.
| Income Tax | 780,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.14% in the last 52 weeks. The beta is 2.34, so ALGS's price volatility has been higher than the market average.
| Beta (1Y) | 2.34 |
| 52-Week Price Change | -42.14% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 0.78 |
| Relative Strength Index (RSI) | 37.16 |
| Average Volume (30 Days) | 402,759 |
Short Selling Information
The latest short interest is 838,464, so 1.12% of the outstanding shares have been sold short.
| Short Interest | 838,464 |
| Short Previous Month | 657,205 |
| Short % of Shares Out | 1.12% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 1.68 |
Income Statement
In the last 12 months, ALGS had revenue of $13.79 million and -$99.59 million in losses. Loss per share was -$1.04.
| Revenue | 13.79M |
| Gross Profit | 13.79M |
| Operating Income | -86.26M |
| Pretax Income | -98.81M |
| Net Income | -99.59M |
| EBITDA | -83.36M |
| EBIT | -86.26M |
| Loss Per Share | -$1.04 |
Balance Sheet
The company has $112.96 million in cash and $10.49 million in debt, giving a net cash position of $102.47 million or $1.37 per share.
| Cash & Cash Equivalents | 112.96M |
| Total Debt | 10.49M |
| Net Cash | 102.47M |
| Net Cash Per Share | $1.37 |
| Equity / Book Value | 59.80M |
| Book Value Per Share | 0.80 |
| Working Capital | 99.18M |
Cash Flow
In the last 12 months, operating cash flow was -$79.36 million and capital expenditures -$81,000, giving a free cash flow of -$79.44 million.
| Operating Cash Flow | -79.36M |
| Capital Expenditures | -81,000 |
| Free Cash Flow | -79.44M |
| FCF Per Share | -$0.51 |
Margins
Gross margin is 100.00%, with operating and profit margins of -625.40% and -722.06%.
| Gross Margin | 100.00% |
| Operating Margin | -625.40% |
| Pretax Margin | -716.41% |
| Profit Margin | -722.06% |
| EBITDA Margin | -604.38% |
| EBIT Margin | -625.40% |
| FCF Margin | -575.96% |
Dividends & Yields
ALGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -263.91% |
| Shareholder Yield | -263.91% |
| Earnings Yield | -192.87% |
| FCF Yield | -153.84% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 84.11% |
| EPS Growth Forecast (5Y) | -30.90% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALGS has an Altman Z-Score of -6.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.44 |
| Piotroski F-Score | 4 |